title: 8-methoxypsoralen plus UVA (PUVA) therapy normalizes signalling of phosphorylated component of mTOR pathway in psoriatic skin of K5.hTGFβ1 transgenic mice.
authors.affiliation: Center for Medical Research, Medical University of Graz, Graz, Austria.|Research Unit for Photodermatology, Department of Dermatology and Venereology, Medical University of Graz, Graz, Austria.
authors.forename: Nitesh
authors.initials: N
authors.lastname: Shirsath
authors.affiliation: Research Unit for Photodermatology, Department of Dermatology and Venereology, Medical University of Graz, Graz, Austria.
authors.forename: Gerlinde
authors.initials: G
authors.lastname: Mayer
authors.affiliation: Center for Medical Research, Medical University of Graz, Graz, Austria.|Research Unit for Photodermatology, Department of Dermatology and Venereology, Medical University of Graz, Graz, Austria.
authors.forename: Tej Pratap
authors.initials: TP
authors.lastname: Singh
authors.affiliation: Research Unit for Photodermatology, Department of Dermatology and Venereology, Medical University of Graz, Graz, Austria.
authors.forename: Peter
authors.initials: P
authors.lastname: Wolf
mesh_terms: D000818:Animals; D008822:Mice, Transgenic; D011701:PUVA Therapy; D010766:Phosphorylation; D011565:Psoriasis / Q000378:metabolism / Q000628:therapy*; D038601:Ribosomal Protein S6 / Q000378:metabolism*; D058570:TOR Serine-Threonine Kinases / Q000378:metabolism*
chemical_list: D038601:Ribosomal Protein S6; C546843:mTOR protein, mouse; D058570:TOR Serine-Threonine Kinases
keywords: PUVA; mammalian target of rapamycin (mTOR); psoralen; psoriasis; transgenic mouse model